Baxter director granted 12,836 common shares
Craig Jeffrey A reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Craig Jeffrey A reported acquisition or exercise transactions in this Form 4 filing.
Baxter International director Jeffrey A. Craig received an equity grant of 12,836 shares of Baxter common stock on May 5, 2026. The shares were granted at no cost as fully vested stock, subject to the applicable grant terms. Following this award, Craig directly holds 23,662 shares, a figure that also reflects automatic reinvestment of dividends.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock, $1 par value | 12,836 | $0.00 | $0.00 |
Footnotes (2)
- F1. The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.
- F2. Total includes the automatic reinvestment of dividends.
Key Figures
Key Terms
automatic reinvestment of dividends financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Baxter (BAX) report for Jeffrey A. Craig?
Was the Baxter (BAX) Form 4 transaction a market purchase or a grant?
Does the Baxter (BAX) Form 4 mention dividend reinvestment for Craig’s holdings?
AI-generated analysis. How Rhea-AI works. Not financial advice.